News | May 06, 2024
Zydus Wellness launches pilot for ready-to-drink beverage Glucon-D Activors
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
The company has posted net profit of Rs.30.35 crores for the Financial Year ended March 31, 2024
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
The project funding will be done through a mix of internal accruals and debts.
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
Subscribe To Our Newsletter & Stay Updated
